Browse > Article
http://dx.doi.org/10.7742/jksr.2017.11.4.205

The Usefulness of Liver Fibroscan Test Using Ultrasound Image  

An, Hyun (Department of Radiology, Inje University Busan Paik Hospital)
Lee, Jin-Soo (Department of Radiology, Inje University Haeundae Paik Hospital)
Im, In-Chul (Department of Radiological Science, Dongeui University)
Yang, Sung-Hee (Department of Radiology, Ilsin Christian Hospital)
Publication Information
Journal of the Korean Society of Radiology / v.11, no.4, 2017 , pp. 205-212 More about this Journal
Abstract
Chronic diffuse hepatopathy is one of the important clinical tasks to reduce mortality and morbidity due to liver cirrhosis, liver failure, and liver cancer. The purpose of this study was to evaluate the criteria for predicting liver and chronic liver disease using Fibroscan based on ultrasound diagnosis. Serum and liver stiffness measurement(kPa) were analyzed in 280 patients and cut-off values of liver stiffness measurement for predicting fatty liver and chronic diffuse hepatopathy were determined using ROC curve analysis. Bilirubin and PT(prothrombin time) were not related to disease prediction(p=0.243, p=0.115). Serum glucose and triglyceride levels were significantly higher in the liver (p<0.05). The cut-off value for predicting chronic diffuse hepatopathy was determined as 10.3 kPa(AUC 0.98, sensitivity 94.94%, specificity 94.93%) in the order of control group, fatty liver and chronic diffuse hepatopathy. Therefore, it will be used as a primary tool for the diagnosis of chronic liver disease patients with quantitative evaluation.
Keywords
Fatty liver; Chronic diffuse hepatopathy; Fibroscan;
Citations & Related Records
연도 인용수 순위
  • Reference
1 F. Piccinino, E. Sagnelli, G. Pasquale, G. Giusti, "Complications following percutaneous liver biopsy, A multicentre retrospective study on 68,276 bbipsies", Journal of hepatology, Vol. 2, No. 2, pp. 85-87, 2016.
2 D. B. McGill, J. Rakela, A. R. Zinsmeister, B. J. Ott, "21-year experience with major hemorrhage after percutaneous liver biopsy", The american journal of gastroenterology, Vol. 99, No. 5, pp. 1396-1400, 1990.   DOI
3 Y. J. Jo, "Changes in liver stiffness measurement using Fibroscan of acute hepatitis", The graduate school of Gachon University, 2012.
4 E. S. Kim, Y. S. Seo, K. G. Lee et al, "The efficacy of measuring liver stiffness for the assessment of liver fibrosis in patients with chronic liver disease", The Korean Association of internal Medicine, Vol. 74, No. 3, pp. 264-270, 2008.
5 P. Nahon, A. Kettaneh, B. Tengher et al, "Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease", Journal of Hepatology, Vol. 49, No. 6, pp. 1062-1068, 2008.   DOI
6 L. Sandrin, B. Fourquet, J. M. Hasquenoph et al, "Transient elastography, a new noninvasive method for assessment of hepatic fibrosis", Official Journal of the World Federation for Ultrasound in Medicine and Biology, Vol. 29, No. 12, pp. 1705-1713, 2003.   DOI
7 H. S. Lee, "Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis", The graduate school of Ajou University, Vol. 16, No. 4, pp. 369-375, 2010.
8 N. Ganne-Carrie, M. Zio, V. de Ledinghen et al, "Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver disease", Journal of hepatology, Vol. 44, No. 6, pp. 1511-1517, 2006.   DOI
9 A. Kettaneh, P. Marcellin, C. Douvin et al, "Feature associated with success rate and performance of Fibroscan measurement for the diagnosis of cirrhosis in HCV patients", Journal of hepatology, Vol. 46, No. 4, pp. 628-634, 2007.   DOI
10 U. Arena, F. Vizzutti, G. Corti et al, "Acute viral hepatitis increases liver stiffness values measured by transient elastography", Journal of hepatology, Vol. 48, No. 1, pp. 349-350, 2008.   DOI
11 D. M. Bissel, J. J. Maheer, Hepatic fibrosis and cirrhosis. In: D. Zakim, T. D. Boyer, ed. Hepatology: A textbook of liver disease. Philadelphia: W. B. Saunders, pp. 506-525, 1998.
12 D. Li, S. L. Friedman, "Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy". J Gastroenterol Hepatol, Vol. 14, No. 7, pp. 618-633, 1999.   DOI
13 R. Bataller, D. A. Brenner, "Liver fibrosis". The Journal of Clinical Investigation, Vol. 115, No. 4, pp. 209-218, 2005.   DOI
14 D. W. Kim, G. T. Park, D. H. Go, et al, "Five-year Follow-up of Clinical and Laboratory Data of Early Liver Cirrhosis Patients Confirmed by Liver Biopsy", Korean Association for the Study of th Liver, Vol. 8, No. 3, pp. 256-263, 2006.
15 P. Gines, A. Cardenas, V. Arroyo, J. Rodes, "Management of cirrhosis and ascites", The New England Journal of Medicine, Vol. 350, No. 16, pp. 1646-1654, 2004.   DOI
16 S. Sheila, D. James, "Diseases of the liver and biliary system" 10th edition, Malden: Blackwell Science, pp. 371-373, 1997.